…System Atrophy, Progressive Supranuclear Palsy, Corticobasal degeneration The European Commission published information on the EUROPA websiteon the call for new members. The exact date of the launch of the call… […]
…inform and support clinical practice. The third focus is on scientific advice. In the United States, we are often called upon to sit on scientific advisory committees, for example, and… […]
…drug on the clinical course of HD. Dosing is also being paused on the open label extension study, GEN-EXTEND. This decision is the outcome of a pre-planned review of the… […]
…drug on the clinical course of HD. Dosing is also being paused on the open label extension study, GEN-EXTEND. This decision is the outcome of a pre-planned review of the… […]
…My interest in Huntington’s disease comes from meeting and talking to HD families as a junior doctor. From that point I knew I wanted to use my research… […]
…predict the age-at-onset or progression of HD. We are aiming to make new algorithms available to the community — covering a large array of applications such as for example analysis/integration… […]
…and research context. With the genomics era on the horizon, our gained knowledge on genetic modifiers and new genetic tools available, I foresee that updated guidelines on diagnostics and novel… […]
…The MDS-ES and EHDN Joint Online Course Series: Huntington’s Disease: From Foundational Principles to Assessment and Treatment is available for free on-demand access through the MDS Education Roadmap. To… […]
…Disease Network we want to thank you for your participation in the EHDN2022 Plenary Meeting on Friday – Sunday, September 16-18, 2022 Program Download [PDF] Meeting-Report: Under Review Abstracts Published… […]
…the capacity of the network to deliver intrathecal treatment, to take steps to improve this, to provide training and good practice guidelines. We aim to guide the process of HTA… […]
